新发黑色素瘤与痣相关黑色素瘤的多中心对比研究
该多中心回顾性研究纳入2006至2015年欧洲、澳大利亚和美国七个中心的9474例局限性黑色素瘤,比较新发黑色素瘤与痣相关黑色素瘤的差异。结果显示新发黑色素瘤与更厚肿瘤及身体部位差异相关,且这些差异在T1期薄黑色素瘤中同样存在,支持两者发病途径不同。
要点
- 新发黑色素瘤比痣相关黑色素瘤肿瘤更厚,且身体部位分布不同。
- 在T1期薄黑色素瘤中同样存在身体部位差异,提示差异非因痣残留被掩盖。
- 新发黑色素瘤较少出现消退现象,支持 divergent pathway 模型。
核心结论
- 新发黑色素瘤与痣相关黑色素瘤在临床病理特征和身体部位上存在差异,支持 divergent pathway 发育模型,且这些差异在薄黑色素瘤中同样存在。
研究设计与样本
- 多中心回顾性研究,纳入2006至2015年欧洲、澳大利亚和美国七个转诊中心的9474例局限性黑色素瘤,比较新发黑色素瘤与痣相关黑色素瘤。
主要发现
- 新发黑色素瘤与更厚肿瘤及身体部位差异相关。
- 在T1期黑色素瘤(n=5307)中,多变量分析显示相似的身体部位差异。
- 新发黑色素瘤较少出现消退现象。
临床怎么用
- 临床评估黑色素瘤时应考虑新发与痣相关类型在年龄、性别、身体部位及组织学亚型上的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether melanoma in histological contiguity with a naevus [naevus-associated melanoma (NAM)] is distinctly different from melanoma arising de novo remains unclear. OBJECTIVES: To determine whether the characteristics of de novo melanoma differ from NAM and are not due to naevus obliteration in thicker tumours. METHODS: We conducted a multicentre retrospective study of de novo melanoma and NAM in seven referral centres in Europe, Australia and the USA between 2006 and 2015. RESULTS: In a total of 9474 localized melanomas, de novo melanoma was associated with thicker tumours and body site differences compared with NAM. In the subset of T1 melanomas (n = 5307), similar body site differences were found in multivariate analysis by body site. When compared with NAM, de novo melanoma was more likely to affect older individuals (≥ 70 years) when located on the head/neck [odds ratio (OR) 4·65, 95% confidence interval (CI) 2·55-8·46], the trunk (OR 1·82, 95% CI 1·40-2·36) or the upper extremity (OR 1·69, 95% CI 1·14-2·50), was more likely to affect female patients when located on the lower extremities (OR 1·36, 95% CI 1·03-1·80), and was more likely to be of the nodular melanoma subtype (OR 2·23, 95% CI 1·14-4·35) when located on the trunk. De novo melanoma was less likely to have regression present compared with NAM. CONCLUSIONS: Clinicopathological and body site differences between de novo melanoma and NAM support the divergent pathway model of development. These differences were also found in thin melanomas, suggesting that de novo melanomas are different from NAM and their differences are not due to the obliteration of naevus remnants in thicker tumours.
引用
- Dessinioti C, Geller AC, Stergiopoulou A, et al. A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences. Br J Dermatol. 2021. PMID: 33454993. doi:10.1111/bjd.19819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。